Orion

Orion Corporation is a Finnish pharmaceutical company that develops, manufactures, and markets a range of human and veterinary pharmaceuticals, active pharmaceutical ingredients, and diagnostic tests. The company's research and development efforts primarily target central nervous system disorders, oncology, and respiratory diseases, with a particular emphasis on innovative treatment methods and products such as the Easyhaler® for pulmonary conditions. Orion serves a diverse clientele, including specialists, general practitioners, veterinarians, pharmacies, hospitals, and laboratories. While the company is primarily focused on the Finnish market, it also extends its operations to other European countries, North America, and additional international markets.

Jari Karlson

CFO, Finance

Hilpi Rautelin

Board Member and Vice Chairman

1 past transactions

Visionplus

Venture Round in 2012
VisionPlus is a venture capital firm based in Helsinki, Finland, established in 2011. The company focuses on investing in digital products, including applications, games, and services across various digital platforms. Its investment strategy encompasses software-as-a-service, gaming, mobile applications, and internet services. Additionally, VisionPlus occasionally engages in special content intellectual property deals. The firm's management team possesses substantial expertise in technology and entrepreneurship, with experience in seed investments and the successful development of new products and services. Members of the team have also led large-scale development and business organizations in a global context.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.